Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclosporin to reduce reperfusion injury in primary percutaneous coronary intervention
ISRCTN27767229Phase 3Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Mar 2015
- Modality
- Small Molecules, Peptides
01
Overview
Phase 3, randomised, double-blind trial in myocardial ischemia-reperfusion injury and myocardial infarction (MI) comparing Ciclosporin with Placebo (2 arms). Primary endpoint: Infarct size. Started Mar 2015; status: completed.
02
Drugs
cyclosporine
03
Conditions
myocardial ischemia-reperfusion injurymyocardial infarction (MI)
Beyond the preview
Go deeper on ISRCTN27767229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN27767229.